White coat hypertension is associated with a greater all-cause mortality

Basit Öğe Kaydı
dc.contributor.authorRami Helvaci, Mehmet
dc.contributor.authorKaya, Hasan
dc.contributor.authorSeyhanli, Mahmut
dc.contributor.authorCosar, Emine
dc.date.accessioned2024-09-18T20:59:12Z
dc.date.available2024-09-18T20:59:12Z
dc.date.issued2007
dc.departmentHatay Mustafa Kemal Üniversitesien_US
dc.description.abstractBackground: Prognostic significance of white coat hypertension (WCH) remains controversial and most of the studies have just focused on the progression to hypertension (HT) or whether or not it already causes target organ damage. Methods: We studied consecutive adults and eldelies with sustained normotension (NT), WCH, and HT applying to the Internal Medicine Polyclinic. A 10 day twice daily measurement of blood pressure at home (HBP) was obtained in all cases, and a 24 hr ambulatory blood pressure monitoring (ABPM) was performed just for the cases with higher office and/or HBP measurements. Prevalences of smoking, overweight, obesity, impaired glucose tolerance, type II diabetes mellitus, hyperbetalipoproteinemia, hypertriglyceridemia, and dyslipidemia were calculated in each group and results were compared in between. Comparison of proportions was used as the statistical analysis method. Results: The study totally included 169 cases, 54 with sustained NT, 66 with WCH, and 49 with HT. The 115 patients with WCH and HT were both diagnosed via HBP and ABPM, and no difference was observed between the two methods for the diagnosis of WCH and masked or obvious HT. Except the smoking and overweight, almost all of the above disorders showed a stepwise and significant progression in frequencies from sustained NT toward WCH and HT. Conclusions: WCH should preferentially be accepted as a disorder associated with a greater all-cause mortality, rather than a predisposing factor of HT or atherosclerosis alone, and its management should be focused on the above comorbid disorders.en_US
dc.identifier.doi10.1248/jhs.53.156
dc.identifier.endpage160en_US
dc.identifier.issn1344-9702
dc.identifier.issn1347-5207
dc.identifier.issue2en_US
dc.identifier.scopus2-s2.0-34047123151en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage156en_US
dc.identifier.urihttps://doi.org/10.1248/jhs.53.156
dc.identifier.urihttps://hdl.handle.net/20.500.12483/12452
dc.identifier.volume53en_US
dc.identifier.wosWOS:000246387400002en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherPharmaceutical Soc Japanen_US
dc.relation.ispartofJournal of Health Scienceen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectsustained normotensionen_US
dc.subjectwhite coat hypertensionen_US
dc.subjecthypertensionen_US
dc.titleWhite coat hypertension is associated with a greater all-cause mortalityen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Tam Metin / Full Text
Boyut:
82.54 KB
Biçim:
Adobe Portable Document Format
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu